Precor competitors

Matthew E. Monaghan is an independent director who joined the Board in October 2016, and is a member of the Audit Committee and Nominating and Corporate Governance Committee. Mr. Monaghan currently serves as President and Chief Executive Officer at Invacare Corporation (NYSE:IVC) (“Invacare”), a medical device manufacturer for the home and long-term healthcare markets, a position he has held since April 2015. Mr. Monaghan was named Chairman of the Invacare Board in May 2015. He previously served as Senior Vice President, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. (formerly known as Zimmer Holdings, Inc.) (“Zimmer”), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products from 2014 to 2015. Mr. Monaghan also has served as Operating Executive for Texas Pacific Group from 2006 to 2009 and at Cerberus Capital Management from 2003 to 2005. He started his career with 13 years in the aerospace, medical and other industrial businesses of General Electric. Mr. Monaghan is a trustee of Cleveland Clinic Avon Lake Hospital. Mr. Monaghan was a member of the board of directors of CD Diagnostics, Inc. from 2012 to 2016 and served as the chairman of the Audit Committee from 2012 to 2015 and as chairman of the board from 2015 to 2016. He holds a Bachelor’s degree in Mechanical Engineering from Cornell University, a Master’s degree in Mechanical Engineering from MIT and an MBA from INSEAD Business School in France.

A transformative and forward-thinking senior executive and top corporate officer with a proven track record of global and domestic accomplishment in strategic sales, marketing, negotiations, cost streamlining, strategic partnerships, product development, commercial brand matrix, brand strategy and identity, and team leadership. Expertise in brands and categories, global P&L, and organizational turn-around. An agile frontrunner known for adding value, resolving complex issues, forming strong relationships, and creating unparalleled business success. Experienced Division President and Corporate Officer for mid-sized, publicly traded corporation having regular exposure to an Independent Board of Directors, key stakeholders (buy-side and sell-side), stock analysts and Wall Street events. Demonstrated success in leading companies to grow revenue while driving profitability through organic expansion combined with M&A activities and strategic partnerships. Particular strengths include change leadership and organizational team building. Recognized for the ability to create Followership corporately and across the greater sports and fitness industry. Widely respected as an advocate for increased focus on childhood obesity and its effect on individuals and society. Specialties: • Culture Change - Willingness to get teams Comfortable being Uncomfortable • Creating the Vision • Eye for Talent - Identifying and Developing “Mental Athletes” • Approachable Leadership • Global Experience • Brand Management, Development and Positioning • Key account negotiations • Relationship builder • Complex Strategic Planning and Execution • Cross-functional team collaboration • Turn-around Expertise

Luke Caruso is a President & COO at Ottawa Dental Laboratory Ltd and is based in Greater Chicago Area. He studied at Kois Center between 2009 and 2011 and University of Iowa between 1997 and 2001.

Gulam Khan is an Operating Partner at Shore Capital Partners, Manager:Advanced Engineering at Us Endoscopy, and Board Member at Summit Medical and is based in Cleveland, Ohio. He has worked as Director:Technical Innovation at Us Endoscopy; President, CEO and Co-Chairman at Us Endoscopy; and Founder at Onyx Advisors. Gulam works or has worked as Board Member at Shore Capital Partners. He studied at Weatherhead School of Management between 1997 and 2000, University of Michigan between 1985 and 1989, and CASE WESTERN RESERVE UNIVERSITY.